Skip to Main Content

Author Details

Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
1999
179
57
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36493348Correction to "Assessing the Activation of Tyrosine Kinase KIT through Free Energy Calculations".J Chem Theory Comput2023
37725576Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.Clin Cancer Res2023
37494095Searching for molecular hypoxia sensors among oxygen-dependent enzymes.Elife2023
37254128Correction: Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.Mol Neurodegener2023
37141099Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activity.Cell Rep2023
37169961Signal peptide mimicry primes Sec61 for client-selective inhibition.Nat Chem Biol2023
37131250Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.Mol Neurodegener2023
35089788Modulating environmental signals to reveal mechanisms and vulnerabilities of cancer persisters.Sci Adv2022
36173843Structure-based discovery of nonopioid analgesics acting through the α<sub>2A</sub>-adrenergic receptor.Science2022
36166736Assessing the Activation of Tyrosine Kinase KIT through Free Energy Calculations.J Chem Theory Comput2022
36161872Cysteine Oxidation in Proteins: Structure, Biophysics, and Simulation.Biochemistry2022
36375339Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues.Int J Parasitol Drugs Drug Resist2022
32887758The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-<sup>11</sup>C-YJH08 PET.J Nucl Med2021
33883744Gasdermin D pore structure reveals preferential release of mature interleukin-1.Nature2021
33904404Protomer alignment modulates specificity of RNA substrate recognition by Ire1.Elife2021
33761256A Crowding Barrier to Protein Inhibition in Colloidal Aggregates.J Med Chem2021
33563661Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.Cancer Discov2021
33635645Mutagenesis, Hydrogen-Deuterium Exchange, and Molecular Docking Investigations Establish the Dimeric Interface of Human Platelet-Type 12-Lipoxygenase.Biochemistry2021
34500187Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.Bioorg Med Chem2021
34507163Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.Bioorg Med Chem2021
34029049<i>In Vitro</i> Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2.Biochemistry2021
34165961Analogs of the Dopamine Metabolite 5,6-Dihydroxyindole Bind Directly to and Activate the Nuclear Receptor Nurr1.ACS Chem Biol2021
33315406Synthesis and Screening of α-Xylosides in Human Glioblastoma Cells.Mol Pharm2021
3240433415-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.J Lipid Res2020
33048542Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1.Biochemistry2020
32968273Synthetic group A streptogramin antibiotics that overcome Vat resistance.Nature2020
32324389Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by Human 15-Lipoxygenase and 12-Lipoxygenase and Its Regulation through Negative Allosteric Modulators.Biochemistry2020
30307134Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.Mol Inform2019
31270078ATP-Competitive Inhibitors Midostaurin and Avapritinib Have Distinct Resistance Profiles in Exon 17-Mutant KIT.Cancer Res2019
31398187Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30/TFEB transcriptional response.PLoS Genet2019
31099551Multi-Granulin Domain Peptides Bind to Pro-Cathepsin D and Stimulate Its Enzymatic Activity More Effectively Than Progranulin in Vitro.Biochemistry2019
30853418Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite.Cell Chem Biol2019
31054975Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins.Mol Cell2019
30878184Structure-based identification of novel CK2 inhibitors with a linear 2-propenone scaffold as anti-cancer agents.Biochem Biophys Res Commun2019
30992364Tau repeat regions contain conserved histidine residues that modulate microtubule-binding in response to changes in pH.J Biol Chem2019
30961890Conformational Dynamics of the HIV-Vif Protein Complex.Biophys J2019
30565457Probing the Electrostatic and Steric Requirements for Substrate Binding in Human Platelet-Type 12-Lipoxygenase.Biochemistry2019
30690031Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.J Mol Biol2019
29377793Prediction of enzymatic pathways by integrative pathway mapping.Elife2018
29953808Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).J Med Chem2018
30532032Inhibitor binding mode and allosteric regulation of Na<sup>+</sup>-glucose symporters.Nat Commun2018
29476136A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.Nat Commun2018
29414793High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex.J Biol Chem2018
28874603Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.Sci Signal2017
28170244Structure-Activity Relationship and Molecular Mechanics Reveal the Importance of Ring Entropy in the Biosynthesis and Activity of a Natural Product.J Am Chem Soc2017
28337324Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin.ACS Med Chem Lett2017
28981251Development of 5N-Bicalutamide, a High-Affinity Reversible Covalent Antiandrogen.ACS Chem Biol2017
29045152Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.J Med Chem2017
29091768Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.Cell Rep2017
28837668Prominent features of the amino acid mutation landscape in cancer.PLoS One2017
  • 1 - 50 of 179

Recommended Authors

The Hebrew University of Jerusalem
Career Start Year 2007
Number of shared co-authors 8
University of California San Diego
Career Start Year 2007
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 1
Elucidata Corporation
Career Start Year 2005
Number of shared co-authors 2
Stony Brook University
Career Start Year 2005
Number of shared co-authors 11
The State University of New Jersey
Career Start Year 2003
Number of shared co-authors 12
University of California
Career Start Year 2001
Number of shared co-authors 6
Institute of Bioengineering
Career Start Year 2001
Number of shared co-authors 8
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 14
Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science
Career Start Year 1999
Number of shared co-authors 6
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 2
Diamond Light Source Ltd, Harwell Science & Innovation Campus
Career Start Year 1998
Number of shared co-authors 11
Boston University
Career Start Year 1997
Number of shared co-authors 10
University Lille, CNRS
Career Start Year 1996
Number of shared co-authors 8
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Career Start Year 1994
Number of shared co-authors 2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 4
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 5
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 6
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 7
The Francis Crick Institute
Career Start Year 1989
Number of shared co-authors 9
University of Washington
Career Start Year 1988
Number of shared co-authors 36
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 10
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 1
Boston University
Career Start Year 1987
Number of shared co-authors 5
Sanford-Burnham-Prebys Medical Discovery Institute
Career Start Year 1987
Number of shared co-authors 5
University of California
Career Start Year 1985
Number of shared co-authors 8
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 5
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 9
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 6
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 14

Collaborators

Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 38
Albert Einstein College of Medicine
Co-authored papers 19
University of Illinois at Urbana-Champaign
Co-authored papers 16
University of California san francisco
Co-authored papers 13
ShanghaiTech University, China iHuman Institute
Co-authored papers 11
University of California San Francisco
Co-authored papers 10
University of California Santa Cruz
Co-authored papers 10
Albert Einstein College of Medicine
Co-authored papers 9
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 9
Department of Pharmaceutical Chemistry, University of California at San Francisco
Co-authored papers 6
Sandler Center for Drug Discovery, University of California San Francisco
Co-authored papers 6
University of California san francisco
Co-authored papers 6
Cue BioPharma Inc.
Co-authored papers 6
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 6
University of Utah
Co-authored papers 6
Albert Einstein College of Medicine
Co-authored papers 6
University of California San Francisco
Co-authored papers 5
Weill Institute for Neurosciences, University of California San Francisco
Co-authored papers 5
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 5
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 4
New York University Grossman School of Medicine
Co-authored papers 4
Cardiovascular Research Unit, Newark Beth Israel Medical Center
Co-authored papers 4
Carl R. Woese Institute for Genomic Biology , University of Illinois
Co-authored papers 4
Albert Einstein College of Medicine
Co-authored papers 4
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 4
Columbia University Irving Medical Center
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
University of Illinois
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
Texas A&M University, College Station
Co-authored papers 4